Giselle M. Valdes

Giselle M. Valdes

Auto-generated profile, based on publicly available information

Giselle M. Valdes

Department of Biology Massachusetts Institute of Technology Cambridge MA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
CPChanyoung Park
Chanyoung Park
KOKwadwo E. Owusu-Boaitey
Kwadwo E. Owusu-Boaitey
GVGiselle M. Valdes
Giselle M. Valdes
PRPeter W. Reddien
Peter W. Reddien
Regeneration requires mechanisms for producing a wide array of cell types. Neoblasts are stem cells in the planarian Schmidtea mediterranea that undergo fate specification to produce over 125 adult cell types. Fate specification in neoblasts can be regulated through expression of fate-specific transcription factors. We utilize multiplexed error-robust fluorescence in situ hybridization (MERFISH) and whole-mount FISH to characterize fate choice distribution of stem cells within planarians. Fate choices are often made distant from target tissues and in a highly intermingled manner, with neighboring neoblasts frequently making divergent fate choices for tissues of different location and function. We propose that pattern formation is driven primarily by the migratory assortment of progenitors from mixed and spatially distributed fate-specified stem cells and that fate choice involves stem-cell intrinsic processes.

5 August 2025
Verified
Journal Article
Open access
PDF file
DGDavid A. Galambos
David A. Galambos
KLKevin Li
Kevin Li
YMYoki Miliard
Yoki Miliard
GVGiselle M. Valdes
Giselle M. Valdes
Over three million Americans died in 2023, mostly due to age-related diseases such as cancer, heart disease, strokes, and diabetes. Most research of these maladies takes a disease-centric approach; that is, researchers consider their causes and treatments to be distinct and somewhat independent. However, an alternative known as the geroscience approach posits that aging can be a distinct biological phenomenon upstream of age-related diseases that can be targeted to prevent many of them simultaneously. In this review, we examine the relative scientific merits of each approach and analyze their current role in the landscape of U.S. biological research funding. Finally, we highlight future research funding opportunities for the prevention of age-related diseases and the extension of healthy lifespan in humans.